Published in J Cancer Res Clin Oncol on August 27, 2014
Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth. PLoS One (2015) 0.79
Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.78
Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma. Cell Rep (2016) 0.78
Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells. Exp Ther Med (2016) 0.77
Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma. Onco Targets Ther (2016) 0.76
Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget (2017) 0.75
Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore) (2017) 0.75
Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA. Drug Des Devel Ther (2017) 0.75
Treating hepatocellular carcinoma with (90)Y-bearing microspheres: a review. Biomedicine (Taipei) (2016) 0.75
Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma. Therap Adv Gastroenterol (2016) 0.75
Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation. Int J Clin Oncol (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Hepatocellular carcinoma. Lancet (2012) 18.09
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology (2003) 11.55
Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst (2008) 11.27
Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med (2004) 10.31
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology (2008) 8.24
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology (2001) 6.88
Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. JAMA (2012) 6.80
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology (2008) 6.75
Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med (2002) 6.64
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Hepatocellular carcinoma: recent trends in the United States. Gastroenterology (2004) 5.90
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg (2006) 5.65
Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 5.29
Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol (2008) 5.24
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol (2006) 5.17
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med (2011) 4.98
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther (2009) 4.98
Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology (2002) 4.83
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol (2009) 4.82
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol (2001) 4.46
Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Ann Intern Med (2012) 4.19
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut (2001) 4.12
Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol (2002) 3.83
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. J Clin Oncol (2013) 3.71
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut (2008) 3.65
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology (2009) 3.57
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology (2010) 3.54
Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study. J Clin Oncol (2013) 3.45
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96
Chemoembolization for hepatocellular carcinoma. Gastroenterology (2004) 2.89
Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant (2010) 2.73
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol (2006) 2.67
Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol (2011) 2.61
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology (2008) 2.59
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol (2012) 2.53
MELD Exceptions and Rates of Waiting List Outcomes. Am J Transplant (2011) 2.47
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol (2008) 2.36
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology (2010) 2.35
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology (2013) 2.30
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int (2014) 2.26
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology (2009) 2.25
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med (2014) 2.24
Epidemiology of hepatocellular carcinoma. Clin Liver Dis (2001) 2.06
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology (2003) 2.05
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol (2002) 1.85
A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA (1987) 1.83
Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology (1995) 1.72
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl (2003) 1.71
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl (2004) 1.65
Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol (2007) 1.65
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology (1991) 1.63
Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology (2004) 1.61
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology (2001) 1.53
Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg (2005) 1.52
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52
Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol (2009) 1.50
AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology (2003) 1.46
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med (1996) 1.44
Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol (2009) 1.38
Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg (2012) 1.33
High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology (2002) 1.32
Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev (1988) 1.25
A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res (1996) 1.23
Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg (2001) 1.23
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. Hepatology (2014) 1.22
Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med (1994) 1.20
Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol (2012) 1.20
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl (2012) 1.18
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant (2011) 1.18
Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol (2011) 1.17
Earlier presentation and application of curative treatments in hepatocellular carcinoma. Hepatology (2014) 1.15
Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl (2004) 1.14
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study. Eur J Cancer (2013) 1.12
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology (2000) 1.10
Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends. Int J Cancer (2007) 1.10
Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer (2007) 1.09
Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor. Hepatogastroenterology (2003) 1.08
A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list. Hepatology (2012) 1.08
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol (1995) 1.05
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatology (1995) 1.05
Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol (2003) 1.04
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Aliment Pharmacol Ther (2010) 1.03
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol (2013) 1.02
Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol (2014) 1.01
Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10
Aspirin concurrently administered with ranitidine does not delay healing of duodenal ulcer. Aust N Z J Med (1990) 2.04
Endoscopic sclerotherapy using absolute alcohol. Gut (1985) 1.73
Conventional versus on-demand therapy for duodenal ulcer: results of a controlled therapeutic trial. Am J Gastroenterol (1990) 1.40
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29
Spectrum of acute poisoning in adults (10 year experience). J Assoc Physicians India (1984) 1.27
Pancreaticobiliary ductal union in biliary diseases. An endoscopic retrograde cholangiopancreatographic study. Gastroenterology (1989) 1.20
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
Rectal histology in acute bacillary dysentery. Gastroenterology (1986) 1.19
Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut (1986) 1.16
Precipitins to different avaian serum antigens in bird fancier's lung and coeliac disease. Clin Allergy (1978) 1.07
Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel. Gut (1995) 1.07
Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study. Gastrointest Endosc (1999) 1.06
Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut (1984) 1.06
An endoscopic method for removal of duodenal phytobezoars. Gastrointest Endosc (1995) 1.05
Skin test for coeliac disease using a subfraction of gluten. Lancet (1977) 1.04
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Aliment Pharmacol Ther (2010) 1.03
Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. J Clin Gastroenterol (2001) 0.99
Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg (1985) 0.98
Influence of geographical factors in the distribution of pathogenic zymodemes of Entamoeba histolytica: identification of zymodeme XIV in India. Trans R Soc Trop Med Hyg (1984) 0.97
Young v adult cirrhotics: a prospective, comparative analysis of the clinical profile, natural course and survival. Gut (1988) 0.96
Interaction of alcohol and hepatitis C virus infection on severity of liver disease. Dig Dis Sci (1999) 0.96
Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut (1987) 0.93
Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol (1987) 0.90
Corrosive acid ingestion in man - a clinical and endoscopic study. Gut (1984) 0.90
Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients. Aliment Pharmacol Ther (2008) 0.89
Absorption of inorganic and haemoglobin iron in coeliac disease. Br J Haematol (1977) 0.89
Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet (1984) 0.88
Spontaneous expulsion per rectum of an ileal lipoma. Postgrad Med J (1988) 0.87
Low dose antacid therapy for duodenal ulcer. Indian J Gastroenterol (1983) 0.86
Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci (1987) 0.86
Gastric acid secretion in patients with typhoid fever. Gut (1985) 0.86
Major differences in the spectrum of gastrointestinal infections associated with AIDS in India versus the west: an autopsy study. Clin Infect Dis (1996) 0.86
Development of carcinoma in chronic calcific pancreatitis. Int J Pancreatol (1990) 0.85
Endoscopic sclerotherapy for varices in children. J Pediatr Gastroenterol Nutr (1988) 0.84
Pancreatic duct abnormalities in gall stone disease: an endoscopic retrograde cholangiopancreatographic study. Gut (1990) 0.83
Use of micro samples of finger prick blood dried on filter paper for a quick and simple dipstick dot-EIA for diagnosis of amebic liver abscess (ALA). J Clin Lab Anal (1994) 0.83
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int (2013) 0.82
Oesophageal ulceration after sclerotherapy--a complication or an accompaniment? Endoscopy (1986) 0.82
Experimental examination of the direct damaging effects of Giardia lamblia on intestinal mucosal scrapings of mice. Trans R Soc Trop Med Hyg (1985) 0.82
Single intubation technique for the assessment of malabsorption and exocrine pancreatic function. Indian J Med Res (1980) 0.81
Bilirubin glucuronyl transferase activity in the human gastric and duodenal mucosa--a preliminary report. Indian J Med Res (1980) 0.81
Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis. Digestion (1988) 0.81
Study of lymphocyte sub-populations in Giardia infected mice. Ann Trop Med Parasitol (1981) 0.81
Transport studies and enzyme assays in mice infected with human Giardia lamblia. Trans R Soc Trop Med Hyg (1982) 0.80
Recognition of oligosaccharide substrates by N-acetyl-glucosaminyltransferase-V. Carbohydr Res (1988) 0.80
Emergency upper gastrointestinal endoscopy in acute corrosive poisoning. Indian J Med Res (1980) 0.80
Symptomatic hepatic hemangioendothelioma in a newborn. Indian Pediatr (2006) 0.79
Jejunal mucosal morphology in healthy north Indian subjects. J Clin Pathol (1985) 0.79
Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection. Dig Dis Sci (2001) 0.79
Colonic myoelectrical activity in irritable bowel syndrome before and after treatment. Indian J Gastroenterol (1988) 0.79
Factors influencing oesophageal ulcer formation following sclerotherapy. Indian J Gastroenterol (1987) 0.79
Isoenzyme studies of Giardia lamblia isolated from symptomatic cases. Aust J Exp Biol Med Sci (1986) 0.78
Hepatitis A vaccine is not required in adult patients with chronic liver disease in Saudi Arabia. Singapore Med J (2009) 0.77
Comparative evaluation of indirect haemagglutination and immunofluorescence tests in serodiagnosis of giardiasis. Indian J Med Res (1981) 0.77
Colonoscopic polypectomy. North Indian experience. J Assoc Physicians India (1990) 0.77
Isoniazid-induced acute pancreatitis. Ann Intern Med (1994) 0.77
Intestinal uptake of nutrients and brush border enzymes in normal and thymectomised Giardia lamblia infected mice. Indian J Med Res (1982) 0.77
Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial. Q J Med (1989) 0.77
Do chillies influence healing of duodenal ulcer? Br Med J (Clin Res Ed) (1984) 0.77
Endoscopic pancreatography in chronic pancreatitis of the tropics. Digestion (1985) 0.77
Pathogenesis of malabsorption in Giardia infection: an experimental study in rats. Trans R Soc Trop Med Hyg (1980) 0.76
Expression of N-acetylglucosaminyltransferase V mRNA in mammalian tissues and cell lines. Glycobiology (1994) 0.76
Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study. Indian J Gastroenterol (1986) 0.76
Post-cholecystectomy syndrome due to a broken T-tube. Indian J Gastroenterol (1991) 0.75
Effect of milk on patients with duodenal ulcers. Br Med J (Clin Res Ed) (1986) 0.75
Editorial: sepsis in cirrhosis - there may be trouble ahead; authors' reply. Aliment Pharmacol Ther (2014) 0.75
Comparison of truncal hair distribution in alcoholic liver disease and alcohol-related chronic pancreatitis. J Gastroenterol Hepatol (2001) 0.75
Study of amebic antigen and antibody in experimental amoebiasis. Indian J Pathol Microbiol (1980) 0.75
Five-year follow-up of hepatitis B surface antigen positive healthy voluntary blood donors: a preliminary observation. Indian J Med Microbiol (2006) 0.75
Adenocarcinoma in Barrett's oesophagus presenting as a polyp. J Assoc Physicians India (1988) 0.75
Long term behaviour of healed duodenal ulcer with and without maintenance therapy. J Assoc Physicians India (1990) 0.75
Functional tumour of the organ of Zuckerkandl: some diagnostic and therapeutic aspects. Indian J Cancer (1980) 0.75
Acute varicella hepatitis in human T-cell lymphotrophic virus types I and II infection. J Gastroenterol (1996) 0.75
Pyoderma gangrenosum in ulcerative colitis. J Assoc Physicians India (1991) 0.75
Premorbid hair growth over the trunk and severity of alcohol-related liver disease. Dig Dis Sci (1998) 0.75
Sucralfate in ulcerative colitis. Gastroenterology (1988) 0.75
Need for antibiotics before sclerotherapy in cirrhotics with acute variceal bleeding. Indian J Gastroenterol (2001) 0.75
Splenoportovenography: safety, success rate and hemodynamic changes, and incidence and natural history of splenic hematoma. Indian J Gastroenterol (1991) 0.75
Traveler's diarrhea-I. Definition, etiology and epidemiology. Trop Gastroenterol (1990) 0.75
Endoscopic sphincterotomy--experience with 110 patients. Indian J Gastroenterol (1989) 0.75
Endoscopic treatment of bile duct stones: is stone extraction necessary after endoscopic sphincterotomy? Trop Gastroenterol (1996) 0.75
Pathogenesis of peptic ulcer in rheumatoid arthritis. J Assoc Physicians India (1991) 0.75
Optimal management of alcoholic hepatitis. Minerva Gastroenterol Dietol (2014) 0.75
Separate pancreatic and biliary ductal openings in alcoholic chronic pancreatitis. Indian J Gastroenterol (1991) 0.75
Oesophageal stricture in dystrophic epidermolysis bullosa--multiple dilatation with gruntzig balloon catheter. Trop Gastroenterol (1995) 0.75
Profile of serum gastrin levels after a meal in healthy Indian subjects. J Assoc Physicians India (1979) 0.75
Bleeding ileal duplication diagnosed by pertechnetate scan. Indian J Gastroenterol (2004) 0.75
Emergency endoscopy in the diagnosis of upper G.I. haemorrhage in patients with portal hypertension. J Assoc Physicians India (1979) 0.75
Role of amoebic antigen in diagnosis of bloody diarrhoea. Indian J Med Res (1982) 0.75
Effect of thyroxin on the transport and metabolic functions of the small intestine in albino rats. Indian J Med Res (1981) 0.75
The whirlpool jet technique for removal of pancreatic duct ascaris. Gastrointest Endosc (1997) 0.75
Antigenaemia in cases of amoebic liver abscess. Indian J Med Res (1980) 0.75
Celiac disease and tropical calcific pancreatitis. Am J Gastroenterol (1993) 0.75
Neutrophil function in coeliac disease. Digestion (1981) 0.75